Accession Number: | 0000899243-21-004170 |
Date: | 2021-01-31 |
Issuer: | QUOTIENT LTD (QTNT) |
Original Submission Date: |
SHROFF ZUBEEN
C/O GALEN PARTNERS,
680 WASHINGTON BLVD
STAMFORD, CT 06901
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
ORDINARY SHARES | 2021-01-31 | M | 7,528 | a | $0.00 | 68,803 | direct | ||
ORDINARY SHARES | 2021-01-31 | 0 | $0.00 | 7,329,074 | indirect | f2 |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2021-01-31 | deemed execution date | M | 6,044 (d) | ordinary shares 6,044 | $0.00 | 18,132 | direct | |||
RESTRICTED STOCK UNITS | 0.0 | 2021-01-31 | deemed execution date | M | 1,484 (d) | ordinary shares 1,484 | $0.00 | 4,450 | direct | |||
ORDINARY SHARES OPTION (RIGHT TO BUY) | 11.62 | 2021-01-31 | deemed execution date | 0 ( ) | 2025-10-31 | ordinary shares 7,505 | $11.62 | 7,505 | direct | |||
ORDINARY SHARES OPTION (RIGHT TO BUY) | 8.0 | 2021-01-31 | deemed execution date | 0 ( ) | 2024-04-29 | ordinary shares 5,000 | $8.00 | 5,000 | direct | |||
ORDINARY SHARES OPTION (RIGHT TO BUY) | 9.95 | 2021-01-31 | deemed execution date | 0 ( ) | 2024-10-31 | ordinary shares 5,025 | $9.95 | 5,025 | direct | |||
ORDINARY SHARES OPTION (RIGHT TO BUY) | 5.73 | 2021-01-31 | deemed execution date | 0 ( ) | 2026-10-31 | ordinary shares 8,726 | $5.73 | 8,726 | direct | |||
ORDINARY SHARES OPTION (RIGHT TO BUY) | 5.21 | 2021-01-31 | deemed execution date | 0 ( ) | 2027-10-31 | ordinary shares 9,597 | $5.21 | 9,597 | direct | |||
ORDINARY SHARES OPTION (RIGHT TO BUY) | 6.41 | 2021-01-31 | deemed execution date | 0 ( ) | 2028-10-31 | ordinary shares 6,240 | $6.41 | 6,240 | direct | |||
ORDINARY SHARES OPTION (RIGHT TO BUY) | 7.78 | 2021-01-31 | deemed execution date | 0 ( ) | 2029-10-31 | ordinary shares 8,158 | $7.78 | 8,158 | direct | |||
ORDINARY SHARE OPTION (RIGHT TO BUY) | 4.55 | 2021-01-31 | deemed execution date | 0 ( ) | 2030-10-31 | ordinary shares 13,611 | $4.55 | 13,611 | direct |
ID | footnote |
---|---|
f1 | restricted stock units convert into ordinary shares on a one-for-one basis. |
f2 | includes 6,613,590 ordinary shares held of record by galen v, 564,780 ordinary shares held by galen international v, and 150,704 ordinary shares held of record by galen management, llc. mr. shroff is amanaging director of galen management, llc, and shares voting and dispositive power over the securities held by galen v, galen international v and galen management, llc. the reporting person disclaimsbeneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein. |
f3 | all 7,505 options have vested and remain exercisable. |
f4 | all 5,000 options have vested and remain exercisable |
f5 | all 5,025 options have vested and remain exercisable. |
f6 | all 8,726 options have vested and remain exercisable. |
f7 | all 9,597 options have vested and remain exercisable. |
f8 | 4,160 options have vested and remain exercisable, and 2,080 options will vest on october 31, 2021. |
f9 | 2,719 options vested on october 31, 2020 and remain exercisable, and the remaining 5,439 options will vest in two equal annual installments on october 31, 2021 and october 31, 2022. |
f10 | on october 31, 2020, the reporting person was granted 24,176 restricted stock units, of which 6,044 have vested and have been exercised. the remaining 18,132 restricted stock units will vest in three equal installments on april 30, 2021, july 31, 2021 and october 31, 2021. |
f11 | on october 31, 2020, the reporting person was granted 5,934 restricted stock units, of which 1,484 have vested and have been exercised. the remaining 4,450 restricted stock units will vest in three equal installments on april 30, 2021, july 31, 2021 and october 31, 2021. |
f12 | the options vest and become exercisable on october 31, 2021. |